Article By:
ChinaBio® Today
Saturday, April 10, 2021 12:55 PM EDT
Sorrento Therapeutics will acquire ACEA Therapeutics in a deal worth up to $488 million. Both companies develop novel cancer drugs, both are headquartered in San Diego and both have operations in China.